Advancing critical care medicine with stem cell therapy and hypothermia for cerebral palsy.
about
Hypothermia inhibits the proliferation of bone marrow-derived mesenchymal stem cells and increases tolerance to hypoxia by enhancing SUMOylation.Syngeneic transplantation of newborn splenocytes in a murine model of neonatal ischemia-reperfusion brain injury.Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response.Comparison of the efficacy of cord blood mononuclear cells (MNCs) and CD34+ cells for the treatment of neonatal mice with cerebral palsy.Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study
P2860
Advancing critical care medicine with stem cell therapy and hypothermia for cerebral palsy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advancing critical care medici ...... ypothermia for cerebral palsy.
@en
Advancing critical care medici ...... ypothermia for cerebral palsy.
@nl
type
label
Advancing critical care medici ...... ypothermia for cerebral palsy.
@en
Advancing critical care medici ...... ypothermia for cerebral palsy.
@nl
prefLabel
Advancing critical care medici ...... ypothermia for cerebral palsy.
@en
Advancing critical care medici ...... ypothermia for cerebral palsy.
@nl
P2093
P2860
P1433
P1476
Advancing critical care medici ...... ypothermia for cerebral palsy.
@en
P2093
Cesar V Borlongan
Harry van Loveren
Mibel Pabon
Naoki Tajiri
Sandra Acosta
Travis Dailey
Yuji Kaneko
Yusef Mosley
P2860
P304
P356
10.1097/WNR.0000000000000062
P577
2013-12-01T00:00:00Z